Table 1.
Colony formation of long-term cell survival condition of HepG2 and PLC/PRF/5 after 9 days treatment of AM and AD.
| AD (μg/mL) | Number of colonies/wella | AM (μg/mL) | Number of colonies/wella |
|---|---|---|---|
| HepG2 | |||
| 0 | 485.67 ± 42.8 | 0 | 585.67 ± 28.2 |
| 3 | 469.67 ± 35.5∗ | 5 | 578 ± 66.9 |
| 6 | 331.33 ± 18.1∗ | 40 | 455.33 ± 72.8∗ |
| 9 | 81.33 ± 16.0# | 20 | 406.67 ± 58.1∗ |
| 12 | 24.33 ± 11.1# | 30 | 17.33 ± 4.51# |
| 15 | 0# | 40 | 0# |
|
| |||
| PLC/PRF/5 | |||
| 0 | 421.67 ± 32.5 | 0 | 431 ± 13.5 |
| 3 | 311 ± 12∗ | 5 | 344 ± 19.7∗ |
| 6 | 263.67 ± 23.96∗ | 10 | 286.67 ± 6.11∗ |
| 9 | 15.67 ± 10.1# | 20 | 9.33 ± 3.05# |
| 12 | 0# | 30 | 0# |
| 15 | 0# | 40 | 0# |
aData are given as mean ± SD from three independent experiments.
∗ P < 0.05 indicates significant difference from the untreated control.
# P < 0.01 indicates significant difference from the untreated control.